Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

Pulmonary Arterial Hypertension (PAH) is an often-overlooked yet life-altering disease that affects thousands globally, requiring lifelong management, rigorous monitoring, and substantial emotional ...

If you have pulmonary hypertension, it means you have high ... You may not have any symptoms at first, but it's really important to get treated quickly. So tell your doctor right away if you ...

You have full access to this article via your institution. Pulmonary arterial hypertension (PAH) is a chronic progressive disease characterized by endothelial cell (EC) dysfunction, substantial ...

Pulmonary hypertension (PH) can be challenging for healthcare professionals to diagnose because of its vague symptoms, such as fatigue and shortness of breath. These symptoms, which may be mild ...

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

Unfortunately, clinical symptoms of PAH are unspecific and are late manifestations of the disease. [3] As in this case, dyspnea on exertion is often the leading clinical symptom; however ...

Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...

Here are common signs and symptoms of pulmonary hypertension as per the American Heart Association: PH develops when the cells lining the walls of the pulmonary arteries undergo changes that make ...

Effects of the combination of bosentan and sildenafil versus sildenafil monotherapy on pulmonary arterial hypertension (PAH) (Compass-2). ClinicalTrials.gov. Updated February 4, 2025. Accessed ...

Treatments are available for improving the symptoms and delaying the progression of PAH, but the disease remains incurable. Various treatments that are currently undergoing phase 2 and 3 clinical ...

Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System ...